74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Progyny Inc
Open
SectorHealthcare
22.77 -1
Overview
Share price change
24h
Min
21.94
Max
23.12
Income | 111K 11M |
|---|---|
Sales | 12M 298M |
P/E Sector Avg | 38.517 63.778 |
EPS | 0.42 |
Profit margin | 3.529 |
Employees | 675 |
EBITDA | 3.3M 16M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +17.54% upside |
Next Earnings | 8 May 2025 |
|---|
Market Cap | -53M 1.9B |
|---|---|
Previous open | 23.77 |
Previous close | 22.77 |
News Sentiment
By Acuity
17%
83%
30 / 386 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Progyny Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Progyny Inc Forecast
Price Target
By TipRanks
17.54% upside
12 Months Forecast
Average 27.14 USD 17.54%
High 34 USD
Low 23 USD
Based on 10 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.
Sentiment
By Acuity
30 / 386 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
